Jonathan S. Berek

Jonathan S. Berek is the Laurie Kraus Lacob Professor at Stanford University School of Medicine, where he serves as Director of the Stanford Women's Cancer Center and Senior Advisor to the Stanford Cancer Institute. He also holds the position of Executive Director of the Stanford Health Communication Initiative and Director of MedArts Films at the Stanford Center for Health Education.

His academic appointments include Professor in the Department of Obstetrics & Gynecology - Gynecologic Oncology, and membership in both Bio-X and the Stanford Cancer Institute. Previously, he served as Chair of the Department of Obstetrics and Gynecology from 2005 to 2017.

Dr. Berek's research focuses on gynecologic oncology, particularly ovarian cancer, cervical cancer, uterine cancer, and vulvar cancer. His work encompasses cancer staging, surgical management, chemotherapy approaches, and patient quality of life assessment in recurrent disease. He has made significant contributions to understanding prognostic factors and developing patient-reported outcome measures for ovarian cancer patients.

His recent publications demonstrate expertise in cancer staging systems, quality of life assessment in clinical trials, novel therapeutic approaches like PARP inhibitors, and the application of advanced technologies like single-cell mass cytometry to understand tumor heterogeneity in ovarian cancer.

Dr. Berek holds leadership positions in multiple professional organizations:

• Chair of the FIGO Women's Cancer Committee (2021-Present)
• Member of the International Committee of the American Society of Clinical Oncology (2017-Present)
• Member of the Executive Committee of the Gynecologic Cancer InterGroup (2017-Present)
• Member of the Executive Committee of the Cervical Cancer Research Network (2017-Present)

He previously served as Past President of both the Council of University Chairs of Obstetrics and Gynecology and the International Gynecologic Cancer Society, demonstrating his international leadership in the field of gynecologic oncology.